The activation of beta-adrenergic system has been associated with a upregulation of the expression of specific oncogenic signaling pathways including Sirtuin-1(Sirt-1) in cervical cancer, Src in ovarian cancer and Human Epidermal Growth Factor Receptor2 (Her2) in breast cancer [12,13]. This evidence concerns the gene SRC and ovarian carcinoma.